Literature DB >> 1825070

Diagnosis and prevalence of persistent chlamydia infection in infertile women: tissue culture, direct antigen detection, and serology.

H Thejls1, J Gnarpe, O Lundkvist, G Heimer, G Larsson, A Victor.   

Abstract

Specimens for chlamydial culture, direct fluorescent antibody (DFA) test, two enzyme immunoassays (EIA) for antigen detection, and serum for chlamydial antibodies were collected from 256 infertile women. Specimens were taken from the tubes during tuboplasty and from the cervix and endometrium during laparoscopy or tuboplasty. Antibodies to Chlamydia trachomatis were found four times more often in patients with signs of prior pelvic inflammatory disease (PID) than in infertile women with normal pelvic findings. Only 48 (37%) of 131 patients with signs of prior PID had a history of PID. Ten or more C. trachomatis elementary bodies (EBs) per smear were found in 21 (8.2%) of 256 patients. Six patients had a positive culture or a positive antigen EIA test. All six had high numbers of EBs in the DFA test. We conclude that routine culture and EIA antigen tests detect only a minority of persistent chlamydia infections in this population, but subjective factors in the interpretation of DFA methods must be considered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825070

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  13 in total

1.  Role of CD8 T cells in primary Chlamydia infection.

Authors:  D M Magee; D M Williams; J G Smith; C A Bleicker; B G Grubbs; J Schachter; R G Rank
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

2.  Reactivation of persistent Chlamydia trachomatis infection in cell culture.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

3.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

4.  Relation between antibodies to Chlamydia trachomatis and spontaneous abortion following in vitro fertilization.

Authors:  F Licciardi; J A Grifo; Z Rosenwaks; S S Witkin
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

5.  Detection of serum antibodies to Chlamydia trachomatis in patients with chlamydial and nonchlamydial pelvic inflammatory disease by the IPAzyme Chlamydia and enzyme immunoassay.

Authors:  A Mattila; A Miettinen; P K Heinonen; K Teisala; R Punnonen; J Paavonen
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 6.  Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis.

Authors:  W L Beatty; R P Morrison; G I Byrne
Journal:  Microbiol Rev       Date:  1994-12

Review 7.  Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Authors:  Rajnish Sahu; Richa Verma; Saurabh Dixit; Joseph U Igietseme; Carolyn M Black; Skyla Duncan; Shree R Singh; Vida A Dennis
Journal:  Expert Rev Vaccines       Date:  2018-02-06       Impact factor: 5.217

8.  Chlamydial serology in genital infections: ImmunoComb versus Ipazyme.

Authors:  A Clad; U Flecken; E E Petersen
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

9.  Fibrinolysis in the peritoneal fluid during adhesions, endometriosis and ongoing pelvic inflammatory disease.

Authors:  G Edelstam; I Lecander; B Larsson; B Astedt
Journal:  Inflammation       Date:  1998-08       Impact factor: 4.092

10.  Chlamydia trachomatis-specific antibodies in patients with pelvic inflammatory disease: comparison with isolation in tissue culture or detection with polymerase chain reaction.

Authors:  J J Theunissen; W Minderhoud-Bassie; J H Wagenvoort; E Stolz; M F Michel; F J Huikeshoven
Journal:  Genitourin Med       Date:  1994-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.